Skip to content

Sigmoidoscopy

PROCEDURE17 trials

Sponsors

Bonderup, Ole K., M.D., Cosmo Technologies Ltd, Sidney Kimmel Cancer Center at Thomas Jefferson University, Barbara Ann Karmanos Cancer Institute, National Cancer Institute (NCI)

Conditions

AIDS-Related Anal CarcinomaAbsence of Signs or SymptomsAnal Basaloid CarcinomaAnal Canal Cloacogenic CarcinomaAnal Margin Squamous Cell CarcinomaAnal Non-Keratinizing Squamous Cell CarcinomaAnal Squamous Cell CarcinomaB-Cell Non-Hodgkin Lymphoma

Phase 1

Phase 2

Efficacy and Tolerability of a New Oral Extended-Release Formulation Containing Parnaparin Sodium, Administered Add-on Therapy
CompletedNCT00867438
Cosmo Technologies LtdUlcerative Colitis
Start: 2007-01-31End: 2007-11-30Updated: 2009-03-25
FMT in Ulcerative Colitis-Associated Pouchitis
CompletedNCT02049502
Virginia O. ShafferUlcerative Colitis Associated Pouchitis
Start: 2014-07-31End: 2018-02-01Updated: 2019-03-27
Testing Nivolumab and Ipilimumab With Short-Course Radiation in Locally Advanced Rectal Cancer
Active, not recruitingNCT04751370
National Cancer Institute (NCI)Locally Advanced Rectal Adenocarcinoma, Stage III Rectal Cancer AJCC v8, Stage II Rectal Cancer AJCC v8
Start: 2022-02-08End: 2026-12-31Target: 31Updated: 2026-04-03
Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer
Active, not recruitingNCT04929028
National Cancer Institute (NCI)AIDS-Related Anal Carcinoma, Anal Margin Squamous Cell Carcinoma, Anal Non-Keratinizing Squamous Cell Carcinoma +7
Start: 2022-08-09End: 2031-09-15Target: 40Updated: 2026-04-03
Testing the Addition of an Anti-Cancer Drug, Irinotecan, to the Standard Chemotherapy Treatment (FOLFOX) After Long-Course Radiation Therapy for Advanced-Stage Rectal Cancers to Improve the Rate of Complete Response and Long-Term Rates of Organ Preservation
Active, not recruitingNCT05610163
Alliance for Clinical Trials in OncologyLocally Advanced Rectal Carcinoma, Stage III Rectal Cancer AJCC v8, Stage II Rectal Cancer AJCC v8
Start: 2022-12-08End: 2033-09-30Updated: 2025-09-08
FOLFOX, Botensilimab, and Balstilimab for the Treatment of Localized Rectal Cancer Before Surgery
RecruitingNCT06780787
City of Hope Medical CenterRectal Adenocarcinoma, Stage IIA Rectal Cancer AJCC v8, Stage III Rectal Cancer AJCC v8
Start: 2025-05-20End: 2027-11-05Target: 26Updated: 2025-06-26

Phase 3

Unknown Phase

Related Papers

Journal of Clinical Oncology2026-01-10